BioCentury
ARTICLE | Company News

Bionovo, IP Shakti LLC endocrine/metabolic, cancer news

September 9, 2013 7:00 AM UTC

Menerba, an estrogen receptor beta selective agonist, was in Phase III testing to treat hot flashes in postmenopausal women, but the company could not secure funding for the trial. Bezielle is an aqueous extract from the herb Scutellaria Barbata D. Don of the Lamiaceae family that inhibits glycolysis. The product has completed a Phase I trial to treat metastatic breast cancer. Selea, a selective estrogen receptor beta agonist, has completed preclinical testing to treat vaginal atrophy associated with menopause. ...